Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heron Therapeutics Inc HRTX

Healthcare Biotechnology
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and... see more

Recent & Breaking News (NDAQ:HRTX)

ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - HRTX

GlobeNewswire July 29, 2019

CLASS ACTION UPDATE for CYH, HRTX and EROS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases July 29, 2019

Upcoming Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019

Press Releases July 29, 2019

7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire July 29, 2019

SHAREHOLDER ALERT: HRTX EQT FRED: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Press Releases July 26, 2019

Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Update

GlobeNewswire July 26, 2019

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, ASNA and FRED

Press Releases July 26, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm

Press Releases July 26, 2019

Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Upcoming Deadline

Press Releases July 26, 2019

CLASS ACTION UPDATE for HRTX, FDX and EQT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases July 26, 2019

Zhang Investor Law Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX

GlobeNewswire July 26, 2019

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, DBD and RLGY

Press Releases July 25, 2019

HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 11 Days Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX

GlobeNewswire July 25, 2019

SHAREHOLDER ALERT: HRTX PVTL OMCL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Press Releases July 24, 2019

Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Update

Press Releases July 24, 2019

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc.

Business Wire July 23, 2019

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and FRED

Press Releases July 23, 2019

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MBNKF, HRTX and CLDR

Press Releases July 22, 2019

Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX

GlobeNewswire July 22, 2019

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, CLDR and PYX

Press Releases July 22, 2019